FI896014A0 - Heterocykliska derivat. - Google Patents

Heterocykliska derivat.

Info

Publication number
FI896014A0
FI896014A0 FI896014A FI896014A FI896014A0 FI 896014 A0 FI896014 A0 FI 896014A0 FI 896014 A FI896014 A FI 896014A FI 896014 A FI896014 A FI 896014A FI 896014 A0 FI896014 A0 FI 896014A0
Authority
FI
Finland
Prior art keywords
heterocyclis
derivatives
heterocyclis derivatives
Prior art date
Application number
FI896014A
Other languages
English (en)
Finnish (fi)
Inventor
Philip Neil Edwards
Jean-Marc Marie Mauri Girodeau
Original Assignee
Ici Pharma
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Pharma, Ici Plc filed Critical Ici Pharma
Publication of FI896014A0 publication Critical patent/FI896014A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/04—Seven-membered rings not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI896014A 1988-12-23 1989-12-15 Heterocykliska derivat. FI896014A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP88403313 1988-12-23
EP89401491 1989-05-31

Publications (1)

Publication Number Publication Date
FI896014A0 true FI896014A0 (fi) 1989-12-15

Family

ID=26118235

Family Applications (1)

Application Number Title Priority Date Filing Date
FI896014A FI896014A0 (fi) 1988-12-23 1989-12-15 Heterocykliska derivat.

Country Status (16)

Country Link
US (1) US5098930A (fr)
EP (1) EP0375404B1 (fr)
JP (1) JPH03135975A (fr)
AU (1) AU624663B2 (fr)
CA (1) CA2006377A1 (fr)
DE (1) DE68913022T2 (fr)
DK (1) DK654589A (fr)
ES (1) ES2062051T3 (fr)
FI (1) FI896014A0 (fr)
GB (1) GB8926981D0 (fr)
HU (1) HUT52767A (fr)
IE (1) IE63047B1 (fr)
IL (1) IL92556A (fr)
NO (1) NO895086L (fr)
NZ (1) NZ231665A (fr)
PT (1) PT92699B (fr)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE64358B1 (en) * 1989-07-18 1995-07-26 Ici Plc Diaryl ether heterocycles
US5254581A (en) * 1990-06-21 1993-10-19 Imperial Chemical Industries Plc Pyran derivatives and their use as inhibitors of 5-lipoxygenase
IE911919A1 (en) * 1990-06-21 1992-01-01 Zeneca Ltd Bicyclic heterocyclic compounds
IE911853A1 (en) * 1990-06-21 1992-01-01 Ici Plc Heterocyclene derivatives
EP0462830B1 (fr) * 1990-06-21 1995-10-18 Zeneca Limited Dérivés cycliques d'éther
GB9113137D0 (en) * 1990-07-13 1991-08-07 Ici Plc Thioxo heterocycles
IE913866A1 (en) * 1990-11-28 1992-06-03 Ici Plc Aryl derivatives
US5272173A (en) * 1990-11-28 1993-12-21 Imperial Chemical Industries Plc 5-lipoxygenase inhibitors
IE914005A1 (en) * 1990-12-14 1992-06-17 Zeneca Ltd Novel intermediates
CA2058254A1 (fr) * 1991-01-15 1992-07-16 John Francis Kingston Derives de benzodioxole
AU645159B2 (en) * 1991-01-17 1994-01-06 Ici Pharma Sulphonamide derivatives
US5258399A (en) * 1991-01-17 1993-11-02 Imperial Chemical Industries Plc Sulphonamide derivatives
US5281720A (en) * 1991-02-28 1994-01-25 Merck Frosst Canada, Inc. Pyranylphenyl hydroxyalkylnaphthoic acids as inhibitors of leukotriene biosynthesis
EP0501578A1 (fr) * 1991-02-28 1992-09-02 Merck Frosst Canada Inc. Acides pyranylphényle hydroxyalkylenaphthaléniques et leur utilisation comme inhibiteurs de la biosynthèse de leukotriène
EP0501579A1 (fr) * 1991-02-28 1992-09-02 Merck Frosst Canada Inc. Lactones naphthalèniques comme inhibiteurs de la biosynthèse de leukotriène
US5227399A (en) * 1991-02-28 1993-07-13 Merck Frosst Canada, Inc. Pyranylphenyl naphthalene lactones as inhibitors of leukotriene biosynthesis
EP0505122A1 (fr) * 1991-03-21 1992-09-23 Zeneca Limited Dérivés alpha, alpha-dialkylbenzyle
EP0532239B1 (fr) * 1991-09-10 1995-12-13 Zeneca Limited Dérivés de benzenesulfonamide comme inhibiteurs de 5-lipoxygenase
EP0540165A1 (fr) * 1991-10-03 1993-05-05 Zeneca Limited Dérivés d'acide alcanoique
EP0555067A1 (fr) * 1992-02-07 1993-08-11 Zeneca Limited Dérivés d'hydroxylamine comme inhibiteurs de 5-lipoxygénase
GB9300894D0 (en) * 1992-02-07 1993-03-10 Zeneca Ltd Oxime derivatives
CA2094465A1 (fr) * 1992-04-23 1993-10-24 Pierre Andre Raymond Bruneau Derives de cycloalcane
CA2095005A1 (fr) * 1992-05-12 1993-11-13 Philip Neil Edwards Derives hydroxylamine
EP0570196B1 (fr) * 1992-05-12 1996-03-06 Zeneca Limited Dérivés d'oximes
CA2095006A1 (fr) * 1992-05-12 1993-11-13 Philip Neil Edwards Derives oxime
EP0570197B1 (fr) * 1992-05-12 1995-12-13 Zeneca Limited Dérivés d'hydroxylamine
US5308852A (en) * 1992-06-29 1994-05-03 Merck Frosst Canada, Inc. Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis
US5428060A (en) * 1992-08-27 1995-06-27 Merck Frosst Canada, Inc. Heteroarylnaphthalene lactones as inhibitors of leukotriene biosynthesis
US5252599A (en) * 1992-08-27 1993-10-12 Merck Frosst Canada, Inc. Heteroarylnaphthalene hydroxy acids as inhibitors of leukotriene biosynthesis
US5350744A (en) * 1992-08-27 1994-09-27 Merck Frosst Canada, Inc. Phenylnaphthalene lactones as inhibitors of leukotriene biosynthesis
US5426109A (en) * 1992-08-27 1995-06-20 Merck Frosst Canada, Inc. Phenylnaphthalene hydroxy acids
EP0586229A1 (fr) * 1992-09-01 1994-03-09 Zeneca Limited 3-Hydroxy-3-(akyl-subst.)-pyrrolidines comme inhibiteur de la 5-lipoxygénase
AU4444393A (en) * 1992-09-01 1994-03-10 Zeneca Limited Pyrrolidine derivatives
US5354865A (en) * 1992-09-10 1994-10-11 Abbott Laboratories Phenylmethyl derivatives having lipoxygenase inhibitory activity
GR920100426A (el) * 1992-10-08 1994-06-30 Ici Pharma Παράγωγα βενζολοσουλφοναμιδίου.
AP9400632A0 (en) * 1993-04-29 1995-10-07 Zeneca Ltd Ether derivatives.
NZ266541A (en) * 1993-06-14 1997-11-24 Pfizer Imidazole derivatives, intermediate compounds and pharmaceutical compositions
EP0636624A1 (fr) * 1993-07-27 1995-02-01 Zeneca Limited Dérivés de thiazole comme inhibiteurs de lipoxygénase
IL110280A0 (en) * 1993-07-27 1994-10-21 Zeneca Ltd Thiazole derivatives
ZA945250B (en) * 1993-07-27 1995-01-27 Zeneca Ltd Thiazole derivatives
US5407959A (en) * 1993-11-12 1995-04-18 Abbott Laboratories (Trans-1,4-dialkoxycyclohexyl) substituted arylalkylaryl-arylalkenylaryl-, and arylalkynylarylurea inhibitors of 5-lipoxygenase
US5446062A (en) * 1993-11-12 1995-08-29 Abbott Laboratories ((4-alkoxypyran-4-yl) substituted) ether, arylalkyl-, arylalkenyl-, and arylalkynyl)urea inhibitors of 5-lipoxygenase
WO1995026346A1 (fr) * 1994-03-28 1995-10-05 Pfizer Inc. Derives benzisothiazoles en tant qu'inhibiteurs de la biosynthese de la 5-lipoxygenase
WO1995030669A1 (fr) * 1994-05-06 1995-11-16 Zeneca Limited Derives ether et compositions pharmaceutiques les contenant
WO1999023074A1 (fr) * 1997-11-03 1999-05-14 Aventis Research & Technologies Gmbh & Co. Kg Derives de naphtalene fluores et leur utilisation dans des melanges a cristaux liquides
CA2269561C (fr) * 1998-04-22 2007-06-05 Dainippon Ink And Chemicals, Inc. Derive de naphtalene et composition a cristaux liquides comprenant celui-ci
CA2422675A1 (fr) * 2000-10-03 2002-04-11 Syngenta Participations Ag Herbicides a base de phenylpropynyloxypyridine
US6825221B2 (en) 2001-10-18 2004-11-30 Allergan, Inc. Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
EP1838296B1 (fr) 2004-10-20 2012-08-08 Resverlogix Corp. Flavanoides et isoflavanoides pour la prevention et le traitement de maladies cardio-vasculaires
CA2617213C (fr) 2005-07-29 2014-01-28 Resverlogix Corp. Compositions pharmaceutiques pour la prevention et le traitement de maladies complexes et leur administration par des dispositifs medicaux inserables
SI2118074T1 (sl) 2007-02-01 2014-05-30 Resverlogix Corp. Spojine za preprečevanje in zdravljenje kardiovaskularnih bolezni
PL2346837T3 (pl) 2008-06-26 2015-07-31 Resverlogix Corp Sposoby wytwarzania pochodnych chinazolinonu
US8952021B2 (en) 2009-01-08 2015-02-10 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular disease
CN105859639A (zh) 2009-03-18 2016-08-17 雷斯韦洛吉克斯公司 新的抗炎剂
SI2421533T1 (sl) 2009-04-22 2019-01-31 Resverlogix Corp. Nova protivnetna sredstva
CN103945848B (zh) 2011-11-01 2016-09-07 雷斯韦洛吉克斯公司 被取代的喹唑啉酮的口服即释制剂
WO2014080290A2 (fr) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Amines cycliques servant d'inhibiteurs de bromodomaines
WO2014080291A2 (fr) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Dérivés biaryle servant d'inhibiteurs de bromodomaines
CA2895905A1 (fr) 2012-12-21 2014-06-26 Zenith Epigenetics Corp. Nouveaux composes heterocycliques en tant qu'inhibiteurs de bromodomaine
JO3789B1 (ar) 2015-03-13 2021-01-31 Resverlogix Corp التراكيب والوسائل العلاجية المعتمدة لمعالجة الامراض المتعلقة بالمتممة

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA960676A (en) * 1970-05-21 1975-01-07 Smith Kline And French Canada Ltd. 3-sulfonamido-4-hydroxyphenyl-2-piperidinylcarbinols
US3743737A (en) * 1970-05-21 1973-07-03 Smith Kline French Lab 3-sulfonamido-4-hydroxyphenyl-2-piperindinylcarbinol compositions
US3661917A (en) * 1970-05-21 1972-05-09 Smith Kline French Lab 3-sulfonamido-4-hydroxyphenyl-2-piperidylcarbinols
IE56702B1 (en) * 1982-12-01 1991-11-06 Usv Pharma Corp Antiinflammatory antiallergic compounds
GB8306512D0 (en) * 1983-03-09 1983-04-13 Ici Plc Heterocyclic compounds
NO174506B (no) * 1984-10-30 1994-02-07 Usv Pharma Corp Analogifremgangsmaate ved fremstilling av terapeutisk aktive forbindelser
US4625034A (en) * 1985-02-04 1986-11-25 Usv Pharmaceutical Corp. 1,2-Dihydro; 1,2,3,4-tetrahydro; 5,8 dihydro; and 5,6,7,8-tetrahydroquinoline derivatives
US4839369A (en) * 1985-04-16 1989-06-13 Rorer Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
FR2611714A2 (fr) * 1986-04-23 1988-09-09 Rhone Poulenc Agrochimie Composes a groupements triazole ou imidazole et tetrahydrofuran, utilisation de ceux-ci a titre de fongicides et procedes de preparation
EP0271287A3 (fr) * 1986-12-11 1990-06-13 Merck Frosst Canada Inc. Acides quinoléine dicarboxyliques et leurs amides
US4920133A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
US4920130A (en) * 1987-11-02 1990-04-24 Rorer Pharamceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
US4920132A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
US4920131A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
US4918081A (en) * 1988-06-20 1990-04-17 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene d4
EP0349062A1 (fr) * 1988-06-27 1990-01-03 Merck Frosst Canada Inc. Acides quinolineétheralkanoiques
IE64358B1 (en) * 1989-07-18 1995-07-26 Ici Plc Diaryl ether heterocycles

Also Published As

Publication number Publication date
HUT52767A (en) 1990-08-28
EP0375404B1 (fr) 1994-02-09
NZ231665A (en) 1992-02-25
ES2062051T3 (es) 1994-12-16
US5098930A (en) 1992-03-24
AU624663B2 (en) 1992-06-18
PT92699A (pt) 1990-06-29
DK654589A (da) 1990-06-24
PT92699B (pt) 1995-09-12
CA2006377A1 (fr) 1990-06-23
GB8926981D0 (en) 1990-01-17
IL92556A0 (en) 1990-08-31
AU4619889A (en) 1990-06-28
HU896626D0 (en) 1990-02-28
NO895086L (no) 1990-06-25
DK654589D0 (da) 1989-12-21
DE68913022D1 (de) 1994-03-24
IL92556A (en) 1994-04-12
JPH03135975A (ja) 1991-06-10
DE68913022T2 (de) 1994-05-11
IE893880L (en) 1990-06-23
EP0375404A3 (fr) 1991-01-16
IE63047B1 (en) 1995-03-22
EP0375404A2 (fr) 1990-06-27
NO895086D0 (no) 1989-12-18

Similar Documents

Publication Publication Date Title
FI896014A0 (fi) Heterocykliska derivat.
DE122004000043I1 (de) Carbostryril-Derivate.
ATE74125T1 (de) Didehydro-vitamin d3-derivate.
FI853206L (fi) Heterocykliska derivat.
FI895049A0 (fi) Derivat av loeslig t-4.
DE69008682D1 (de) Guanidinobenzolderivate.
DE58901056D1 (de) Dehydrocholecalciferolderivate.
FI891122A (fi) N-cyklopropylaniliner och deras anvaendning i foerfarandet foer framstaellning av 1-cyklopropylkinolonkarboxylsyror och deras derivat.
FI891123A0 (fi) Foerfarande foer framstaellning av 1 -cyklopropylkinolonkarboxylsyror och deras derivat.
ATE124407T1 (de) Chromanderivate.
ATE126800T1 (de) Neplanocinderivate.
FI860622A (fi) Heterocykliska derivat.
DE69017383D1 (de) Substituierte bicycloheptadionderivate.
ATE116985T1 (de) Chromanderivate.
DE68911192D1 (de) Phosphonoalkylpurin-Derivate.
DE69017657D1 (de) Pyridinderivate.
FI891124A (fi) Anordning foer framstaellning av en flerskiktstraeskiva.
FI892761A (fi) Expressionsvektorer foer framstaellning av ofusionerade proteiner i mikroorganismer.
DE58903265D1 (de) Fluorcyclopropyl-derivate.
DE69005904D1 (de) Phenylpyrimidonderivate.
DE59000510D1 (de) N-phenyltetrahydroindazolderivate.
DE68913856D1 (de) Cycloalkylthiazol-Derivate.
DE59003499D1 (de) 3-Cyano-4-phenyl-pyrrol-Derivate.
DE68917170D1 (de) Pyridin-Derivate.
NO892714D0 (no) Substituerte azacykloheksylderivater.

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: ICI PHARMA

Owner name: IMPERIAL CHEMICAL INDUSTRIES PLC